Pharmacist CFO services: steer the pharmacy on script economics, not the till

Split the P&L before you try to steer it

The first deliverable is a P&L that separates the dispensary from the front store, with labour, rent, and shrink allocated honestly between them — because a healthy blended margin can hide a front store losing money behind a dispensary carrying it, or the reverse. Your PMS and POS data already hold the split; most owners have simply never seen it drawn. The same separation drives compliance: prescription drugs are zero-rated while most front-store sales are taxable, so the GST/HST return is only as good as the split behind it — plumbing our bookkeeping team builds before the CFO layer goes on top. The split also shows where payroll dollars work hardest, which matters in a business where staffing is the largest cost you actually control.

Script economics: contribution per fill and per pharmacist-hour

Dispensing fees are effectively set by the payer, so dispensary profit is a volume and workflow game, not a pricing one. Payer mix decides your average fee — provincial plans like ODB, private insurers, and cash all reimburse differently — while generic pricing rules compress ingredient margin, leaving the fee as the profit. That points at two levers we track monthly:

• Contribution per script by payer group, so you know which volume is worth chasing and what a new prescriber relationship is actually worth.
• Contribution per pharmacist-hour — technicians and assistants should absorb the fill workflow so pharmacist time flows to billable clinical work: minor-ailment prescribing, injections, and medication reviews where your province funds them.

Expanded-scope services are the rare pharmacy revenue line where the constraint is your schedule rather than a reimbursement table, which is exactly why they deserve a plan instead of leftover time. We also watch the workflow itself — scripts per staff-hour, peak-hour wait times — because the fee per fill is fixed but the labour cost per fill is not.

The front store: small margins, real cash

The front store earns its keep only if you manage it like retail — margin per shelf-foot, inventory turns, and shrink — because convenience traffic will not forgive dead stock. We look at which categories actually turn, how much cash sits in slow inventory, and whether front-store staffing matches the sales curve or just the opening hours. For many stores the honest answer is a smaller, tighter front store and more space or attention on clinical services; the numbers make that call unemotional. Seasonal buying deserves the same discipline — a cough-and-cold order placed on last year's habit rather than this year's sell-through is how back rooms fill with dead stock.

Banner or independent: model the fees against your volume

A banner is a purchasing and marketing co-op you pay for; whether it pays you back depends on your volume, not on the brochure. The comparison worth running:

We put your actual purchase mix through both columns. Sometimes the banner discount dwarfs the fees; sometimes it quietly does not.

Buying a pharmacy: financing a goodwill-heavy deal

Most of a pharmacy's price is goodwill — the script files — so lenders underwrite the cash flow, and your diligence has to protect it. Before the offer firms up we examine script-count trends by payer, prescriber concentration (a pharmacy fed by one clinic inherits that clinic's risk), pharmacist and staff retention, and lease security. The financing stack is typically a bank healthcare-lending team or BDC term debt, often with a vendor take-back that keeps the seller invested in a smooth handover. We model debt service against post-close cash flow with a buffer for reimbursement changes — provincial fee schedules move, and a deal that only works at today's ODB rates is thinner than it looks. Inventory is the other diligence layer: a purchase price that quietly includes stale or short-dated stock is a discount you negotiate before closing, not a write-off you absorb after. Border-city owners and US-trained pharmacists carry an extra layer — US licensure years, US retirement accounts — covered in our cross-border guide for pharmacists, with sale-side structuring handled by our tax team.